StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.85−0.06 (-2.06%)

Close on Nov 17, 2026Market cap $28.36MP/E –Yield –

Scynexis price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Scynexis's price to book ratio was 0.5× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.5× to 31.8×, with a median of 0.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×−0.2
2025Dec 31, 20250.7×−0.1
2024Dec 31, 20240.8×−0.1
2023Dec 29, 20230.9×−2.1
2022Dec 30, 20223.0×−0.9
2021Dec 31, 20213.9×−4.8
2020Dec 31, 20208.6×+0.1
2019Dec 31, 20198.5×+7.7
2018Dec 31, 20180.8×−1.6
2017Dec 29, 20172.4×+0.2
2016Dec 30, 20162.3×+0.5
2015Dec 31, 20151.7×−0.6
2014Dec 31, 20142.4×–

More Scynexis figures

See a number that looks wrong?